Drug design for G-protein-coupled receptors by a ligand-based NMR method.
about
NMR-based analysis of protein-ligand interactions.Overview of Probing Protein-Ligand Interactions Using NMR.The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonismProgress in structure based drug design for G protein-coupled receptors.NMR in natural products: understanding conformation, configuration and receptor interactions.NMR in drug discovery on membrane proteins.Low affinity GPCRs for metabolic intermediates: challenges for pharmacologists.An NMR-based scoring function improves the accuracy of binding pose predictions by docking by two orders of magnitude.Drug discovery opportunities and challenges at g protein coupled receptors for long chain free Fatty acids.Nanodiscs for INPHARMA NMR Characterization of GPCRs: Ligand Binding to the Human A2A Adenosine Receptor.G-protein coupled receptor and kinase targets: advances in drug discovery from molecular to clinical.Enabling STD-NMR fragment screening using stabilized native GPCR: A case study of adenosine receptor.GPCR Conformations: Implications for Rational Drug Design.Hyperpolarized Binding Pocket Nuclear Overhauser Effect for Determination of Competitive Ligand Binding
P2860
Q30617417-75E790F9-CA46-4DCC-933A-56091AF0176AQ30984731-096D2A4B-4556-42C5-90C3-3221B4B39A16Q37252074-D9921D08-23AF-452E-9880-DAA8DD5CDCD2Q37880053-AE4C2BAE-5535-47C8-A416-25E183259CAEQ37997913-11A436A5-1725-49BB-B6C8-D7D862A0D9ECQ38008722-CAC56EE5-1C68-4B5A-A8C6-F89B8F8EEF19Q38014830-9F455848-50BD-4A9E-8C7E-7416B0CADB4BQ40669788-8C075A96-00EB-4573-95BD-B6106B4F1000Q42174959-9303F9A8-55F9-420A-B3A1-F583C730AB36Q51042844-5EC02DA3-F372-4254-9720-642C85740464Q51690191-A264D55E-1F64-4BFA-A9CB-AE62210C0BCBQ55401243-4BEF2F1E-779C-4301-95EE-159EE9440D69Q55564362-4B6FA9B9-ED64-4974-AD07-31452F6BBB25Q57819580-462F0B55-1E11-41ED-8EF8-1C6112F2C46B
P2860
Drug design for G-protein-coupled receptors by a ligand-based NMR method.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Drug design for G-protein-coupled receptors by a ligand-based NMR method.
@ast
Drug design for G-protein-coupled receptors by a ligand-based NMR method.
@en
Drug design for G-protein-coupled receptors by a ligand-based NMR method.
@nl
type
label
Drug design for G-protein-coupled receptors by a ligand-based NMR method.
@ast
Drug design for G-protein-coupled receptors by a ligand-based NMR method.
@en
Drug design for G-protein-coupled receptors by a ligand-based NMR method.
@nl
prefLabel
Drug design for G-protein-coupled receptors by a ligand-based NMR method.
@ast
Drug design for G-protein-coupled receptors by a ligand-based NMR method.
@en
Drug design for G-protein-coupled receptors by a ligand-based NMR method.
@nl
P2093
P2860
P356
P1476
Drug design for G-protein-coupled receptors by a ligand-based NMR method.
@en
P2093
Christian Griesinger
Elisabeth Defossa
Ingo Focken
K Ulrich Wendt
Siegfried Stengelin
Stefan Bartoschek
Thomas Klabunde
Viktoria Dietrich
P2860
P304
P356
10.1002/ANIE.200905102
P407
P577
2010-02-01T00:00:00Z